全文获取类型
收费全文 | 1494篇 |
免费 | 12篇 |
专业分类
电工技术 | 1篇 |
综合类 | 2篇 |
化学工业 | 67篇 |
金属工艺 | 3篇 |
机械仪表 | 6篇 |
建筑科学 | 63篇 |
能源动力 | 4篇 |
轻工业 | 31篇 |
石油天然气 | 1篇 |
无线电 | 34篇 |
一般工业技术 | 75篇 |
冶金工业 | 1158篇 |
原子能技术 | 5篇 |
自动化技术 | 56篇 |
出版年
2022年 | 3篇 |
2021年 | 12篇 |
2020年 | 3篇 |
2019年 | 8篇 |
2018年 | 12篇 |
2017年 | 2篇 |
2016年 | 4篇 |
2015年 | 10篇 |
2014年 | 12篇 |
2013年 | 13篇 |
2012年 | 10篇 |
2011年 | 22篇 |
2010年 | 21篇 |
2009年 | 19篇 |
2008年 | 28篇 |
2007年 | 26篇 |
2006年 | 22篇 |
2005年 | 11篇 |
2004年 | 15篇 |
2003年 | 13篇 |
2002年 | 9篇 |
2001年 | 7篇 |
2000年 | 8篇 |
1999年 | 33篇 |
1998年 | 366篇 |
1997年 | 199篇 |
1996年 | 128篇 |
1995年 | 75篇 |
1994年 | 78篇 |
1993年 | 61篇 |
1992年 | 15篇 |
1991年 | 21篇 |
1990年 | 7篇 |
1989年 | 20篇 |
1988年 | 16篇 |
1987年 | 14篇 |
1986年 | 18篇 |
1985年 | 19篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1981年 | 7篇 |
1980年 | 9篇 |
1978年 | 4篇 |
1977年 | 24篇 |
1976年 | 75篇 |
1975年 | 5篇 |
1973年 | 4篇 |
1972年 | 2篇 |
1957年 | 1篇 |
1951年 | 1篇 |
排序方式: 共有1506条查询结果,搜索用时 0 毫秒
11.
CB Henk S Grampp P Wiesbauer A Zoubek F Kainberger M Breitenseher GH Mostbeck H Imhof 《Canadian Metallurgical Quarterly》1998,38(6):509-522
Ewing's sarcoma is a highly malignant neoplasm of the bone whose origin is still uncertain. A strong relationship exists between Ewing's sarcoma and tumors of neural origin (Ewing family of tumors). Ewing's sarcoma must be distinguished from other round-cell tumors like lymphoma and neuroblastoma and also must be differentiated from osteogenic sarcomas. On plain radiographs, Ewing's sarcoma appears as a lytic or mixed lytic-sclerotic, rarely as predominantly sclerotic lesion with margins Lodwick grade III. It is located primarily in the diaphyseal and metadiaphyseal regions of the long bones of the lower extremities. A large soft tissue tumor is usually present. Magnetic resonance imaging is the imaging modality of choice to evaluate the extent of the primary lesion, to monitor the response to neoadjuvant chemotherapy and to follow up non-resected Ewing's sarcomas. Bone scintigraphy is necessary to detect skeletal metastasis, and 201thallium scanning has been shown to be sensitive in the monitoring of treatment response. Today, computed tomography is not longer used to image the tumor site; however, spiral CT of the lungs plays a central role as a staging and follow-up tool. 相似文献
12.
The mechanism of neurite penetration of three-dimensional fibrin matrices was investigated by culturing embryonic chick dorsal root ganglia (DRGs) within fibrin gels, upon fibrin gels, and upon laminin. The length of neurites within three-dimensional matrices of fibrin was decreased in a concentration-dependent manner by agents that inhibited plasmin, e.g. aprotinin, or that inhibited plasminogen activation, e.g., epsilon-aminocaproic acid (EACA), or plasminogen antiserum. In contrast, such agents increased the length of neurites growing out from DRGs cultured upon two-dimensional substrates of fibrin and had no effect on the length of neurites growing out from DRGs cultured upon laminin. Visualization of neurites within three-dimensional fibrin matrices demonstrated that the distance between fibrin strands was much smaller than the diameter of neurites. All these data were consistent with the hypothesis that fibrinolysis localized to the region of the neurite tip is an important mechanism for neurite penetration of a physical barrier of fibrin strands arranged in a three-dimensional matrix. 相似文献
13.
KW Mahaffey CB Granger R Collins CM O'Connor EM Ohman SD Bleich JJ Col RM Califf 《Canadian Metallurgical Quarterly》1996,77(8):551-556
Intravenous heparin is routinely given after thrombolytic therapy for patients with acute myocardial infarction in the United States and in some, but by no means all, other countries. Several trials have documented improved infarct-artery patency in patients treated with heparin; however, none was large enough individually to assess the effect of heparin on clinical outcomes. We performed a systematic overview of the 6 randomized controlled trials (1,735 patients) to summarize the available data concerning the risks and benefits of intravenous heparin versus no heparin after thrombolytic therapy. Mortality before hospital discharge was 5.1% for patients allocated to intravenous heparin compared with 5.6% for controls (relative risk reduction of 9%, odds ratio 0.91, 95% confidence interval 0.59 to 1.39). Similar rates of recurrent ischemia and reinfarction were observed among those allocated to heparin therapy or control. The rates of total stroke, intracranial hemorrhage, and severe bleeding were similar in patients allocated to heparin; however, the risk of any severity of bleeding was significantly higher (22.7% vs 16.2%; odds ratio 1.55, 95% confidence interval 1.21 to 1.98). There was no significant difference in the observed effects of heparin between patients receiving tissue-type plasminogen activator and those receiving streptokinase or anisoylated plasminogen streptokinase activator complex, or between patients who did and did not receive aspirin. The findings of this overview demonstrate that insufficient clinical outcome data are available to support or to refute the routine use of intravenous heparin therapy after thrombolysis. It is not known if these findings are due to lack of statistical power, inappropriate levels of anticoagulation, or lack of benefit of intravenous heparin. Large randomized studies of heparin (and of new antithrombotic regimens) are needed to establish the role of such therapy. 相似文献
14.
15.
CB Granger J Hirsch RM Califf J Col HD White A Betriu LH Woodlief KL Lee EG Bovill RJ Simes EJ Topol 《Canadian Metallurgical Quarterly》1996,93(5):870-878
BACKGROUND: Although intravenous heparin is commonly used after thrombolytic therapy, few reports have addressed the relationship between the degree of anticoagulation and clinical outcomes. We examined the activated partial thromboplastin time (aPTT) in 29,656 patients in the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO-I) trial and analyzed the relationship between the aPTT and both baseline patient characteristics and clinical outcomes. METHODS AND RESULTS: Intravenous heparin was administered as a 5000-U bolus followed by an initial infusion of 1000 U/h, with dose adjustment to achieve a target aPTT of 60 to 85 seconds. aPTTs were collected 6, 12, and 24 hours after thrombolytic administration. Higher aPTT at 24 hours was strongly related to lower patient weight (P < .00001) as well as older age, female sex, and lack of cigarette smoking (all PT< .0001). At 12 hours, the aPTT associated with the lowest 30-day mortality, stroke, and bleeding rates was 50 to 70 seconds. There was an unexpected direct relationship between the aPTT and the risk of subsequent reinfarction. There was a clustering of reinfarction in the first 10 hours after discontinuation of intravenous heparin. CONCLUSIONS: Although the relationship between aPTT and clinical outcome was confounded to some degree by the influence of baseline prognostic characteristics, aPTTs higher than 70 seconds were found to be associated with higher likelihood of mortality, stroke, bleeding, and reinfarction. These findings suggest that until proven otherwise, we should consider the aPTT range of 50 to 70 seconds as optimal with intravenous heparin after thrombolytic therapy. 相似文献
16.
CB McCoy SA Smith LR Metsch RS Anwyl R Correa L Bankston JJ Zavertnik 《Canadian Metallurgical Quarterly》1994,2(4):267-274
Socioeconomic status is the most significant factor influencing the decreased survival associated with breast cancer in minority groups in the United States. Barriers to the use of early detection programs by low-income women often result in the detection of breast cancer at stages too advanced to assure optimum outcomes. In an effort to increase accessibility of breast cancer screening among such individuals, the Early Detection Program (EDP) was initiated in 1987. The program provided breast cancer screening to women 40 years of age and older who attended eight primary healthcare centers located in low-income neighborhoods throughout Dade County, Florida. From its inception in October 1987 through December 1993, 23,866 medically underserved women had mammography examinations, with more than 17,000 of these women undergoing baseline mammograms. Since the program's inception, 126 cancers were diagnosed in 123 women. A dramatic shift from later to earlier stage breast cancers was observed. These results warrant a greater inclusion of medically underserved and lower socioeconomic status women in screening programs for the early detection of breast cancer. 相似文献
17.
J Seoane K Trinh RM O'Doherty AM Gómez-Foix AJ Lange CB Newgard JJ Guinovart 《Canadian Metallurgical Quarterly》1997,272(43):26972-26977
Glucose-6-phosphatase (G6Pase) catalyzes the hydrolysis of glucose 6-phosphate (Glu-6-P) to free glucose and, as the last step in gluconeogenesis and glycogenolysis in liver, is thought to play an important role in glucose homeostasis. G6Pase activity appears to be conferred by a set of proteins localized to the endoplasmic reticulum, including a glucose-6-phosphate translocase, a G6Pase phosphohydrolase or catalytic subunit, and glucose and inorganic phosphate transporters in the endoplasmic reticulum membrane. In the current study, we used a recombinant adenovirus containing the cDNA encoding the G6Pase catalytic subunit (AdCMV-G6Pase) to evaluate the metabolic impact of overexpression of the enzyme in primary hepatocytes. We found that AdCMV-G6Pase-treated liver cells contain significantly less glycogen and Glu-6-P, but unchanged UDP-glucose levels, relative to control cells. Further, the glycogen synthase activity state was closely correlated with Glu-6-P levels over a wide range of glucose concentrations in both G6Pase-overexpressing and control cells. The reduction in glycogen synthesis in AdCMV-G6Pase-treated hepatocytes is therefore not a function of decreased substrate availability but rather occurs because of the regulatory effects of Glu-6-P on glycogen synthase activity. We also found that AdCMV-G6Pase-treated-cells had significantly lower rates of lactate production and [3-3H]glucose usage, coupled with enhanced rates of gluconeogenesis and Glu-6-P hydrolysis. We conclude that overexpression of the G6Pase catalytic subunit alone is sufficient to activate flux through the G6Pase system in liver cells. Further, hepatocytes treated with AdCMV-G6Pase exhibit a metabolic profile resembling that of liver cells from patients or animals with non-insulin-dependent diabetes mellitus, suggesting that dysregulation of the catalytic subunit of G6Pase could contribute to the etiology of the disease. 相似文献
18.
H. Vestweber J. Oberski A. Greiner W. Heitz R. F. Mahrt H. Bssler 《Advanced functional materials》1993,2(4):197-204
The electroluminescent behaviour of films of poly(phenylphenylenevinylene) (PPPV), of PPPV blended with polystyrene (PS) and of PS doped with oligo(phenylenevinylene) sandwiched between indium–tin oxide (ITO) and Al contacts has been investigated. Polymer blending increases the relative quantum efficiency by up to two orders of magnitude. Studying the cell performance under application of rectangular voltage pulses as a function of temperature indicates that (i) hole injection at the ITO contact occurs by tunnelling, (ii) tunnel injection of electrons at the cathode is promoted by a space charge field across an interfacial Al2O3 layers and (iii) leakage of holes through the cathodic barrier is the main loss mechanism for holes. 相似文献
19.
R Kumar M Mandal A Lipton H Harvey CB Thompson 《Canadian Metallurgical Quarterly》1996,2(7):1215-1219
Overexpression of HER2 in estrogen receptor (ER)-positive human breast tumors has been associated with resistance to endocrine therapy. Here we investigated the effects of HER2 on expression of apoptotic pathways and modulation of tamoxifen-induced apoptosis in ER-positive MCF-7 breast cancer cells. We report that HER2 overexpression in MCF-7 cells is accompanied by up-regulation of antiapoptotic Bcl-2 and Bcl-XL proteins and suppression of tamoxifen-induced apoptosis. In addition, human tumor cell lines that are both ER positive and overexpress HER2 also express enhanced levels of Bcl-2 compared to cells that are either ER positive or overexpress HER2 alone. Our findings suggest that possible deregulation of antiapoptotic Bcl-2 and Bcl-XL may be associated with the enhanced survival of HER2-overexpressing and ER-positive breast cancer cells treated with antiestrogens. 相似文献
20.